Liz Hurlburt is executive vice president and head of clinical and medical affairs at CorMedix, a biopharmaceutical company based in New Jersey. Liz has spent the last twenty years in clinical development, including starting multiple research programs and a biomedical research collaborative. Liz has worked within the kidney community since 2007 and is dedicated to bringing innovative therapies and offerings to this special patient population.